These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16362152)

  • 1. Pathogenesis of vascular calcification in dialysis patients.
    Ketteler M; Westenfeld R; Schlieper G; Brandenburg V
    Clin Exp Nephrol; 2005 Dec; 9(4):265-270. PubMed ID: 16362152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into vascular calcification.
    Ketteler M; Giachelli C
    Kidney Int Suppl; 2006 Dec; (105):S5-9. PubMed ID: 17136112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia.
    Ketteler M; Wanner C; Metzger T; Bongartz P; Westenfeld R; Gladziwa U; Schurgers LJ; Vermeer C; Jahnen-Dechent W; Floege J
    Kidney Int Suppl; 2003 May; (84):S84-7. PubMed ID: 12694317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification in patients with end-stage renal disease.
    Floege J; Ketteler M
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V59-66. PubMed ID: 15284362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.
    Shioi A; Nishizawa Y
    J Ren Nutr; 2009 Jan; 19(1):78-81. PubMed ID: 19121777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetuin-A and extraosseous calcification in uremia.
    Ketteler M
    Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):337-42. PubMed ID: 15931001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular calcification and disordered mineral metabolism in dialysis patients.
    Kalpakian MA; Mehrotra R
    Semin Dial; 2007; 20(2):139-43. PubMed ID: 17374088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
    Persy V
    Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
    Qunibi WY; Nolan CA; Ayus JC
    Kidney Int Suppl; 2002 Dec; (82):S73-80. PubMed ID: 12410860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular calcification in dialysis patients: pathogenesis and consequences.
    Reslerova M; Moe SM
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular calcification in patients with end-stage renal disease.
    Pecovnik-Balon B
    Ther Apher Dial; 2005 Jun; 9(3):208-10. PubMed ID: 15966990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural analysis of vascular calcifications in uremia.
    Schlieper G; Aretz A; Verberckmoes SC; Krüger T; Behets GJ; Ghadimi R; Weirich TE; Rohrmann D; Langer S; Tordoir JH; Amann K; Westenfeld R; Brandenburg VM; D'Haese PC; Mayer J; Ketteler M; McKee MD; Floege J
    J Am Soc Nephrol; 2010 Apr; 21(4):689-96. PubMed ID: 20203159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
    Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L
    Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.
    London GM; Marchais SJ; Guérin AP; Métivier F
    Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):525-31. PubMed ID: 16205470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological mechanisms and consequences of cardiovascular calcifications: role of uremic toxicity.
    Chillon JM; Mozar A; Six I; Maizel J; Bugnicourt JM; Kamel S; Slama M; Brazier M; Massy ZA
    Ann Pharm Fr; 2009 Jul; 67(4):234-40. PubMed ID: 19596096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular calcification in chronic kidney disease.
    Jono S; Shioi A; Ikari Y; Nishizawa Y
    J Bone Miner Metab; 2006; 24(2):176-81. PubMed ID: 16502129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis].
    Nitta K
    Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and vascular calcification.
    Moe SM; Chen NX
    Blood Purif; 2005; 23(1):64-71. PubMed ID: 15627739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.